Chlamydia pneumoniae in abdominal aortic aneurysms abundance of membrane components in the absence of heat shock protein 60 and DNA

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 11, 1999, Pages 2680-2686

  Meijer, Adam ^a   Van Der Vliet, J Adam ^b   Roholl, Paul J M ^a   Gielis Proper, Siska K ^a   De Vries, Ankje ^a   Ossewaarde, Jacobus M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Abdominal aortic aneurysms; Atherosclerosis; Chlamydia pneumoniae; Cytomegalovirus; Herpes simplex virus

Indexed keywords

HEAT SHOCK PROTEIN 60;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032724812     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.11.2680     Document Type: Article

References (44)

1. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev. 1995;8:451-461.
2. Saikku P, Leinenen M, Manila K, Ekman MR, Nieminen MS, Mäkelä PH, Huttunen JK, Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983-986.
3. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J. 1992;82:158-161.
4. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841-849.
5. Ramirez JA, the Chlamydia pneumoniae/Atherosclerosis study group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med. 1996;125:979-982.
6. Jackson LA, Campbell LA, Schmidt RA, Kuo CC, Cappuccio AL, Lee MJ, Grayston JT. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol. 1997;150:1785-1790.
7. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 1998;31:827-832.
8. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang SP. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 1995;92:3397-3400.
9. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis. 1997;176:292-295.
10. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997;96:2144-2148.
11. Kuo CC, Coulson AS, Campbell LA, Cappuccio AL, Lawrence RD, Wang SP, Grayston JT, Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg. 1997;26:29-31.
12. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb. 1993;13:1501-1504.
13. Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, Fagetti L, Esposito G, Ruberti U, Allegra L. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol. 1996;34:2766-2769.
14. Juvonen J, Juvonen T, Laurila A, Alakärppä H, Lounatmaa K, Surcel HM, Leinonen M, Kairaluoma MI, Saikku P. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg. 1997;25:499-505.
15. Petersen E, Boman J, Persson K, Amerlöv C, Wadell G, Juto P, Eriksson A, Dahlén G, Ängquist KA. Chlamydia pneumoniae in human abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 1998;15:138-142.
16. Puolakkainen M, Parker J, Kuo CC, Grayston JT, Campbell LA. Further characterization of Chlamydia pneumoniae specific monoclonal antibodies. Microbiol Immunol. 1995;39:551-554.
17. Ossewaarde JM, Manten JW, Hooft HJ, Hekker AC. An enzyme immunoassay to detect specific antibodies to protein and lipopolysaccharide antigens of Chlamydia trachomatis. J Immunol Methods. 1989;123:293-298.
18. Swanson AF, Kuo CC. Evidence that the major outer membrane protein of Chlamydia trachomatis is glycosylated. Infect Immun. 1991;59:2120-2125.
19. Yuan Y, Lyng K, Zhang YX, Rockey DD, Morrison RP. Monoclonal antibodies define genus-specific, species-specific, and cross-reactive epitopes of the chlamydial 60-kilodalton heat shock protein (hsp60): specific immunodetection and purification of chlamydial hsp60. Infect Immun. 1992;60:2288-2296.
20. Meijer A, Van der Vliet JA, Roholl PJM, Schouls LM, Ossewaarde JM. Detection of microorganisms in vessel wall specimens of the abdominal aorta: development of a PCR assay in the absence of a gold standard. Res Microbiol. 1998;149:577-583.
21. Neumaier M, Braun A, Wagener C. Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. Clin Chem. 1998;44:12-26.
22. Greer CE, Peterson SL, Kiviat NB, Manos MM. PCR amplification from paraffin-embedded tissues: effects of fixative and fixation time. Am J Clin Pathol. 1991;95:117-124.
23. Ossewaarde JM, De Vries A, Van den Hoek JAR, Van Loon AM. Enzyme immunoassay with enhanced specificity for detection of antibodies to Chlamydia trachomatis. J Clin Microbiol. 1994;32:1419-1426.
24. Ladany S, Black CM, Farshy CE, Ossewaarde JM, Barmes RC. Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR). J Clin Microbiol. 1989;27:2778-2783.
25. Lentner C, ed. Geigy Scientific Tables. 8th rev ed. Basel, Switzerland: Ciba-Geigy Ltd; 1982.
26. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:1512-1531.
27. Ward ME The immunobiology and immunopathology of chlamydial infections. APMIS. 1995;103:769-796.
28. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol Today. 1995;16:27-33.
29. Heinecke JW. Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid .and molecular chlorine. Biofactors. 1997;6:145-155.
30. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
31. Shah PK. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation. 1997;7:2115-2117.
32. Wills A, Thompson MM, Crowther M, Sayers RD, Bell PRF. Pathogenesis of abdominal aortic aneurysms: cellular and biochemical mechanisms. Eur J Vasc Endovasc Surg. 1996;12:391-400.
33. Capron L. Chlamydia in coronary plaques: hidden culprit or harmless hobo? Nat Med. 1996;2:856-857.
34. Kahane S, Metzer E, Friedman MG. Evidence that the novel microorganism 'Z' may belong to a new genus in the family, Chlamydiaceae. FEMS Microbiol Lett. 1995;126:203-208.
35. Amann R, Springer N, Schönhuber W, Ludwig W, Schmid EN, Müller KD, Michel R. Obligate intracellular bacterial parasites of acanthamoebae related to Chlamydia spp. Appl Environ Microbiol. 1997;63:115-121.
36. Ossewaarde JM, Meijer A. Molecular evidence for the existence of additional members of the order Chlamydiales. Microbiology. 1999;145:411-417.
37. Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, Shani J, Frankel R, Penney K, Quinn TC, Hammerschlag MR, Schachter J. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis. 1996;173:957-962.
38. Lindholt JS, Østergård L, Henneberg EW, Fasting H, Andersen P. Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR). Eur J Vasc Endovasc Surg. 1998;15:161-164.
39. Paterson DL, Hall J, Rasmussen SJ, Timms P. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology. 1998;30:169-172.
40. Fredericks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev. 1996;9:18-33.
41. Maass M, Gieffers J, Krause E, Engel PM, Bartels C, Solbach W. Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients. Med Microbiol Immunol. 1998;187:103-106.
42. Raza-Ahmad A, Klassen GA, Murphy DA, Sullivan JA, Kinley CE, Landymore RW, Wood JR. Evidence of type 2 herpes simplex infection in human coronary arteries at the time of coronary artery bypass surgery. Can J Cardiol. 1995;11:1025-1029.
43. Satta J, Laurila A, Paakko P, Haukipuro K, Sormunen R, Parkkila S, Juvonen T. Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: an immunohistochemical and electron microscopic study. Eur J Vasc Endovasc Surg. 1998;15:313-319.
44. Tanaka S, Komori K, Okadome K, Sugimachi K, Mon R. Detection of cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J Vasc Surg. 1994;20:235-243.